testicular germ cell cancer
Recently Published Documents





2021 ◽  
Vol Volume 14 ◽  
pp. 4853-4858
Koji Kawai ◽  
Akinobu Tawada ◽  
Mizuki Onozawa ◽  
Takamitsu Inoue ◽  
Hiromichi Sakurai ◽  

2021 ◽  
Vol 9 (3) ◽  
pp. 35
David Elad ◽  
Ariel J. Jaffa ◽  
Dan Grisaru ◽  
Ilan Leibovitch

It is well established that the intrauterine biological environment plays important roles in fetal development. In this review, we re-visit the hypothesis that testicular germ cell cancer (TGCC), especially in adolescents and young adults, has been programmed in utero. The origin for extreme in utero environments is mostly maternal driven and may be due to nutritional, physical and psychological stressful conditions that alter the optimal molecular and biophysical in utero environments. Moreover, precursors for TGCC may originate as early as during fertilization or implantation of the blastocyst. Further investigations of human developmental biology, both in vivo and in vitro, are needed in order to establish better understanding of in utero programming of future wellbeing or diseases.

2021 ◽  
Vol 11 (1) ◽  
Mette Pernille Myklebust ◽  
Anna Thor ◽  
Benedikte Rosenlund ◽  
Peder Gjengstø ◽  
Ása Karlsdottir ◽  

AbstractMicroRNA-371a-3p (miR371) has been suggested as a sensitive biomarker in testicular germ cell cancer (TGCC). We aimed to compare miR371 with the classical biomarkers α-fetoprotein (AFP) and β-human chorionic gonadotropin (hCGβ). Overall, 180 patients were prospectively enrolled in the study, with serum samples collected before and after orchiectomy. We compared the use of digital droplet PCR (RT-ddPCR) with the quantitative PCR used by others for detection of miR371. The novel RT-ddPCR protocol showed high performance in detection of miR371 in serum samples. In the study cohort, miR371 was measured using RT-ddPCR. MiR371 detected CS1 of the seminoma and the non-seminoma sub-types with a sensitivity of 87% and 89%, respectively. The total sensitivity was 89%. After orchiectomy, miR371 levels declined in 154 of 159 TGCC cases. The ratio of miR371 pre- and post-orchiectomy was 20.5 in CS1 compared to 6.5 in systemic disease. AFP and hCGβ had sensitivities of 52% and 51% in the non-seminomas. MiR371 is a sensitive marker that performs better than the classical markers in all sub-types and clinical stages. Especially for the seminomas CS1, the high sensitivity of miR371 in detecting TGCC cells may have clinical implications.

2021 ◽  
Vol 3 (2) ◽  
pp. 322-325
Marish I.F.J. Oerlemans ◽  
Gerard Groenewegen ◽  
Aryan Vink ◽  
Linda W. van Laake ◽  
Niels P. van der Kaaij ◽  

2021 ◽  
Vol 10 (8) ◽  
pp. 2897-2903
Eveline A. M. Heijnsdijk ◽  
Steven J. Supit ◽  
Leendert H. J. Looijenga ◽  
Harry J. Koning

João Lobo ◽  
Ricardo Leão ◽  
Ad J.M. Gillis ◽  
Annette van den Berg ◽  
Lynn Anson-Cartwright ◽  

2020 ◽  
Vol 31 ◽  
pp. S600
H.S. Sagstuen Haugnes ◽  
H.F.S. Negaard ◽  
H. Jensvoll ◽  
T. Wilsgaard ◽  
T. Tandstad ◽  

Sign in / Sign up

Export Citation Format

Share Document